Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes is a research paper published in Blood Vessels Thrombosis & Hemostasis (2025). On theSindex it has a DataRank of 0.245. It has been cited 4 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
3.35 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
US Department of Veterans Affairs
Grant: I01CX001932
National Heart, Lung, and Blood Institute
Grant: T32 HL007344
National Heart, Lung, and Blood Institute
Grant: R01 AI162778
National Heart, Lung, and Blood Institute
Grant: HL068835
National Heart, Lung, and Blood Institute
Grant: HL168630
National Institutes of Health
Grant: 5T32HL007344-30
Program in Hematology:&Cell Biology Blood Cells
National Institutes of Health
Grant: 5R01AI162778-04
Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility
National Institutes of Health
Grant: 5I01CX001932-04
Thrombogenic susceptibility in middle aged Veterans
National Institutes of Health
University of Iowa Roy J and Lucille A Carver College of Medicine
National Institute of Allergy and Infectious Diseases
Roy J. Carver Charitable Trust
FWCI
3.08
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords